Dossier · MRCY · Held
MRCY · Mercury Systems Inc · Stock research
Last analysed ·
Current thesis
Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.
Invalidation trigger
A weekly close below $94 loses the breakout base and rising 50-day shelf underpinning the advance. Secondary: a Q4 FY26 print (~2026-08-10 to 08-18) with free cash flow failing to turn positive or book-to-bill under 1.0, or defense-electronics flipping to saturated as KTOS/AVAV break their July lows.
Thesis status
Played out resolved published trigger did not fire How this is scored →Latest analysis and events for MRCY —
As of 2026-08-09, orbyd's latest analysis for Mercury Systems Inc (MRCY): Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.
Invalidation trigger: A weekly close below $94 loses the breakout base and rising 50-day shelf underpinning the advance. Secondary: a Q4 FY26 print (~2026-08-10 to 08-18) with free cash flow failing to turn positive or book-to-bill under 1.0, or defense-electronics flipping to saturated as KTOS/AVAV break their July lows.
Next dated event on file: — catalyst in 9d.
All prices and levels below are market observations, stated as analysis.
Current Thesis
Mercury supplies the layer beneath the platform primes: secure processing modules, RF and microwave subsystems, radar and electronic-warfare hardware, trusted microelectronics, sold into missile, radar and airborne programs. The narrative leg being bought is an operational turnaround — a supplier that spent 2023–2024 missing on acquisition integration and cash conversion, re-rating as bookings recovered and management promised a cash inflection.
Two things changed since the last update, and both cut the same way. First, the Palantir-adjacency bid faded. That volume is under a third of the 1,456,893 that changed hands on 2026-07-17 and roughly half the 781,504 of the 2026-08-04 advance. Two sessions of new attention arrived; a third did not.
Second, the calendar hardened. Mercury confirmed on 2026-07-28 that Q4 and full-year FY26 results come after the close on Tuesday 2026-08-18, with a call at 5:00 p.m. ET. The window in the prior note ("~Aug 10–18") is now a single date. The fundamental record still stops on 2026-05-05 — everything in between is positioning.
No analyst has moved a target since J.P. Morgan's $99→$101 Neutral on 2026-07-13 and Jefferies' $105→$115 Hold on 2026-07-10; the nine-analyst average still reads $103.75, below the 2026-08-07 close. Arguing against a SATURATED read: the structure is intact — price is clear of the 200-day at $88.08 (2026-08-04 reading), the name is still 104% higher over 52 weeks, and an unresolved binary sits nine days out.
Bullish and bearish views on Mercury Systems Inc
The model's bull view on Mercury Systems Inc (MRCY), in brief: Two consecutive quarters of demand extension through the last disclosure. The bear view: No contract value, term, revenue or margin figure was disclosed with the 2026-08-03 agreement. Both cases follow in full.
Bull Case
- Two consecutive quarters of demand extension through the last disclosure. Q2 FY26 printed bookings $288M and book-to-bill 1.23 on backlog approaching $1.5B; Q3 FY26 (quarter ended 2026-03-27, reported 2026-05-05) followed with bookings $348M (+73.7% YoY), book-to-bill 1.48 and backlog roughly $1.6B (+17.9% YoY).
- Guidance moved up on 2026-05-05, not down: FY26 revenue growth raised to mid-single digits from low-single digits, FY26 adjusted EBITDA margin guided to mid-teens. CEO Bill Ballhaus on that call: "we expect Free Cash Flow to be positive for Q4."
- The print is the first chance to convert a promise into a number. Q3 FY26 free cash flow was negative $2M against +$24M a year earlier; the 2026-08-18 release grades the Q4 turn directly.
- Trailing revenue is growing again. TTM revenue $966.95M, +9.0%, as of 2026-08-07 — against an FY26 consensus revenue line of $960.35M.
- Optionality attached on 2026-08-03: a Tradewind-sponsored agreement to build a Palantir Foundry enterprise ontology across Mercury's material planning and factory operations, including a digital twin of the manufacturing footprint. If any throughput or cycle-time figure attaches to it on 2026-08-18, it becomes a margin story rather than a headline.
Bear Case
- No contract value, term, revenue or margin figure was disclosed with the 2026-08-03 agreement.
- Price is above where the sell side marks it. The 2026-08-07 close of $108.64 sits above the nine-analyst average target of $103.75 (high $120, low $74). Goldman Sachs carries Sell at $68 (2026-05-11).
- Valuation carries no cushion. Forward P/E 78.06 as of 2026-08-07, on TTM net income of -$14.10M and TTM EPS of -$0.24. The case has to be argued in adjusted EBITDA and cash because GAAP earnings are negative.
- Consensus for the quarter is not agreed on. Zacks cut its Q4 FY26 EPS estimate to $0.20 from $0.21 on 2026-07-07; ChartMill's fifteen-analyst aggregation shows a $0.40 Q4 EPS consensus and $271.03M revenue (that page also still carried a stale 2026-08-10 report date). Which line a headline compares against will decide "beat" or "miss" on the night.
- The group has stopped paying for good numbers. Kratos beat and raised on 2026-08-04 — Q2 revenue $458.8M, +30.5% YoY versus $410.4M consensus, FY26 guidance raised to $1.75–1.81B — and closed $51.87 against a $134.00 52-week high, with Cantor Fitzgerald cutting its target to $100 from $115 that morning.
- Twelve-month insider flow is one-directional. MarketBeat's log shows 14 insiders selling $207.73M against $506,600 of purchases; the last two open-market sales on record are director Howard L.
Setup & Price Structure
The 2026-08-07 close of $108.64 sits essentially on the 50-day reading of $108.04 from 2026-08-04 and far above the 200-day at $88.08 from the same date. The all-time high remains $128.45 (2026-07-06); the 52-week range is $51.86–$128.45. The base under the advance is the late-July shelf — a 2026-07-29 close of $90.17 (-9.27% on the session the FOMC held at 3.50%–3.75% with three hike dissents) and a 2026-07-31 close of $97.10.
Crowding and positioning observables, stated as observables: short interest 4.81M shares, 8.65% of a 55.53M-share float, 6.12 days to cover, up from 4.64M a month earlier — a reading that predates the four-session move from $90.17 to $112.80, so whether it was covered into that run or added into the print is not yet visible. The 2026-08-07 close is above the analyst average target. An earnings date sits nine calendar days from 2026-08-09. Insider open-market activity has been silent for ten weeks after a 12-month run of one-way selling. Single-day moves have repeatedly exceeded 6% in either direction, in both directions, over the last three weeks.
The structural read: a name that ran 104% in 52 weeks, made its high five weeks ago, drew down roughly 20%, spiked on adjacency, and is now chopping on shrinking volume into a print it cannot avoid. That is consolidation ahead of a binary, and there is no informational edge available before the release. A low-conviction setup on a fresh entry at this level.
Catalyst Calendar (next 30 days)
- 2026-08-14 — Q2 2026 institutional 13F deadline (positions as of 2026-06-30). Shows holder behaviour through the 2026-07-06 all-time high of $128.45 and before the drawdown.
- 2026-08-18 — Q4 and full-year FY26 results, after the close; conference call 5:00 p.m. ET (confirmed by company press release 2026-07-28). Grades the Q4 free-cash-flow turn management guided on 2026-05-05.
- 2026-08-18 — Q4 book-to-bill and closing FY26 backlog, in the same release. Follows readings of 1.23 and 1.48 and backlog of roughly $1.6B.
- 2026-08-18 — First FY27 revenue and margin framing on the call, against FY27 consensus of $1.05B revenue and $1.55 EPS.
- 2026-08-18 — First management commentary on the Palantir agreement in a reportable setting.
- ~2026-08-18 to 2026-08-24 (est.) — FY26 Form 10-K. The FY25 10-K was filed the same day as that year's Q4 release, 2025-08-11.
- ~2026-08-26 (est.) — FINRA short-interest publication covering the mid-August settlement date, the first reading that spans the run from $90.17 to $112.80 and the fade back.
What Would Change Our Mind
The structure that would have to break first is the late-July shelf — the $90.17 close of 2026-07-29 and the $97.10 of 2026-07-31 that the whole August advance was launched from. A weekly close below $94 puts price back inside that shelf and removes the rising-50-day support the re-rating has tracked since spring; the 200-day at $88.08 (2026-08-04) is the next observable level below it.
On fundamentals, the specific things that would flip the read on 2026-08-18: free cash flow failing to turn positive after the "positive for Q4" commitment of 2026-05-05; book-to-bill printing under 1.0; closing FY26 backlog flat-to-down from roughly $1.6B; or an FY27 revenue frame below the $1.05B consensus. On narrative, the read moves to SATURATED if the 2026-08-18 call attaches no contract value, throughput or cycle-time figure to the Palantir agreement and the advance off $97.10 unwinds without further news — or if KTOS and AVAV break their July lows while Mercury's own numbers are fine.
Conversely, what would extend the leg rather than end it: a third consecutive book-to-bill above 1.2, a positive Q4 FCF number with an FY27 frame at or above $1.05B, and a target revision above the $120 street high — none of which exists in the record as of 2026-08-09.
Correlation Notes
- Defense electronics peers. XAR closed $282.09 (+3.09%) on 2026-08-04; MRCY printed roughly double the sector ETF's move that day and 8.95% against XAR's 3.31% the session before. The name has been trading with a Mercury-specific beta to the group, not as a tracker of it.
- Kratos as the read-across on reaction function. KTOS beat and raised on 2026-08-04 and closed $51.87 (+5.41%) on 6,481,826 shares, against a $134.00 52-week high. If a beat is not bought in this group, the 2026-08-18 setup is asymmetric against the bull case regardless of the numbers.
- Palantir as an inherited factor. After 2026-08-03 the name has a documented sensitivity to PLTR headlines. PLTR's 2026-08-04 Q2 (revenue $1.94B, +93% YoY; U.S. commercial $764M, +149%; FY26 guide raised to $8.15–8.16B) coincided with Mercury's second up-session. That works in both directions and carries no Mercury-specific cause.
- Rates and the risk tape. The 2026-07-29 FOMC hold at 3.50%–3.75% with three hike dissents coincided with a 9.27% single-session decline to $90.17. At a forward P/E of 78.06, duration risk in the multiple is a live channel.
- Appropriations. House-passed FY2026 funding levels run through 2026-12-04 and bar DoD new starts; continuing-resolution mechanics push award timing across the whole customer base, not just this name.
Notes
- Fiscal year ends in late June: the 2026-08-18 release is the June-quarter AND full-year report, and the FY25 10-K was filed the same day as that year's Q4 release.
- GAAP loss-making: TTM net income -$14.10M and TTM EPS -$0.24 as of 2026-08-07. Trailing-earnings screens read as undefined; the case is argued in adjusted EBITDA and cash.
- Published FY26/Q4 consensus diverges by source (Zacks Q4 EPS $0.20 vs ChartMill $0.40). Which line a headline uses will decide beat or miss on the night.
- Mercury settled a securities class action for $32.5M covering purchases 2021-02-03 through 2024-02-06; the Q3 FY26 10-Q flags possible additional claims from a large shareholder.
- Management excluded Golden Dome and elevated budget lines from bookings and outlook on the 2026-05-05 call, so budget headlines stay sentiment until they appear in the backlog number.
- Short interest is 8.65% of a 55.53M-share float at 6.12 days to cover; single-day moves have repeatedly exceeded 6% in either direction.
Related · shared themes
XMTR
Xometry, Inc.
Q2 on 2026-08-04 cleared every self-set number — revenue $229.3M (+41%), marketplace +45%, Adj EBITDA $14.1M — and the new CEO raised FY2026 growth to 33–34% from 27–28%. Price took three sessions to agree, closing $93.15 on 08-07 back above the $90.65 50-day, still under the $106.08 July high.
ARCB
ArcBest Corporation
The 2026-08-04 bounce failed: ARCB lost the $136 shelf on a 2026-08-06 close of $135.25 and printed a post-print low of $134.75 on 08-07, while three open-market director sales — the first of 2026 — executed at $138.71–$144.85 on 08-04 and 08-06. Brent's rebound to $83.55 defers the fuel-surcharge unwind. No company checkpoint before the ~2026-10-28 Q3 print.
XPO
XPO, Inc.
Beat-and-raise LTL margin story the tape only half pays for: after Q2 adjusted OR 79.9% and an at-least-200bps full-year guide, price lost the $199–$201 shelf on 2026-08-03 at $197.01 and reclaimed it 2026-08-07 at $202.58 with no company news attached. July Cass (~08-13) and ATA (~08-18) decide whether the above-6% July tonnage is a demand turn or share transfer.
ALNT
Allient Inc.
Record-orders inflection: Q2 2026 bookings $201.3M (+49% YoY), 1.31x book-to-bill, backlog $298.0M vs $236.6M a year earlier — the first clean order break after two flat revenue years. Narrative is ACCELERATING, but the entire re-rating landed in three sessions into a 52-week high of $112.81 (2026-08-07, RSI 75.5) and nothing tests it until the Q3 print.